Clinical Trial Details
Trial ID: | L5171 |
Source ID: | NCT00859079 |
Associated Drug: | Glp-1 |
Title: | Efficacy of GLP-1 Infusion in Comparison to an Insulin Infusion Protocol to Reach Normoglycemia Type 2 Diabetic Patients |
Acronym: | |
Status: | COMPLETED |
Study Results: | NO |
Results: | |
Conditions: | Diabetes Mellitus Type 2|Hyperglycemia |
Interventions: | DRUG: GLP-1|DRUG: Human regular insulin intravenously |
Outcome Measures: | Primary: time to reach a plasma glucose below 115 mg/dl, 0,30,60,120,150,180,210,240,270,300,330,360,390,420,450,480,510 min | Secondary: plasma glucose after 2 and 4 hours as well as maximum glycemia, 0,30,60,120,150,180,210,240,270,300,330,360,390,420,450,480,510 min|number of hypoglycaemic episodes, 0,30,60,120,150,180,210,240,270,300,330,360,390,420,450,480,510 min |
Sponsor/Collaborators: | Sponsor: Medical University of Graz |
Gender: | ALL |
Age: | ADULT, OLDER_ADULT |
Phases: | PHASE4 |
Enrollment: | 8 |
Study Type: | INTERVENTIONAL |
Study Designs: | Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT |
Start Date: | 2006-06 |
Completion Date: | 2007-01 |
Results First Posted: | |
Last Update Posted: | 2009-03-10 |
Locations: | Medical University of Graz, Department for Internal Medicine, Graz, 8036, Austria |
URL: | https://clinicaltrials.gov/show/NCT00859079 |

Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress |
---|